{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:26:53Z","timestamp":1772119613993,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Science and Technology and Biotechnology, Govt. of West Bengal, India"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00733-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:51:24Z","timestamp":1766389884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-scale in-silico modelling to unveil structural requirements for DNA-PK inhibitors as radiosensitizers and MolSHAP based design of novel ligands"],"prefix":"10.1007","volume":"40","author":[{"given":"Soumya","family":"Mitra","sequence":"first","affiliation":[]},{"given":"Rakesh Kumar","family":"Dolai","sequence":"additional","affiliation":[]},{"given":"Nilanjan","family":"Ghosh","sequence":"additional","affiliation":[]},{"given":"Subhash C.","family":"Mandal","sequence":"additional","affiliation":[]},{"given":"Amit Kumar","family":"Halder","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"733_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/cncr.21324","volume":"104","author":"G Delaney","year":"2005","unstructured":"Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104:1129\u20131137. https:\/\/doi.org\/10.1002\/cncr.21324","journal-title":"Cancer"},{"key":"733_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrd4003","volume":"12","author":"EJ Moding","year":"2013","unstructured":"Moding EJ, Kastan MB, Kirsch DG (2013) Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 12:526\u2013542. https:\/\/doi.org\/10.1038\/nrd4003","journal-title":"Nat Rev Drug Discov"},{"key":"733_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","volume":"355","author":"JP Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949\u2013955","journal-title":"Lancet"},{"key":"733_CR4","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1200\/JCO.2007.13.3983","volume":"25","author":"SM Bentzen","year":"2007","unstructured":"Bentzen SM, Trotti A (2007) Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 25:4096\u20134103. https:\/\/doi.org\/10.1200\/JCO.2007.13.3983","journal-title":"J Clin Oncol"},{"key":"733_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00000421-199808000-00008","volume":"21","author":"D Ewing","year":"1998","unstructured":"Ewing D (1998) The oxygen fixation hypothesis: a reevaluation. Am J Clin Oncol 21:355\u2013361","journal-title":"Am J Clin Oncol"},{"key":"733_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H et al (2019) Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer 18:157. https:\/\/doi.org\/10.1186\/s12943-019-1089-9","journal-title":"Mol Cancer"},{"key":"733_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson WR, Hay MP (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11:393\u2013410. https:\/\/doi.org\/10.1038\/nrc3064","journal-title":"Nat Rev Cancer"},{"key":"733_CR8","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","volume":"25","author":"J Overgaard","year":"2007","unstructured":"Overgaard J (2007) Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25:4066\u20134074. https:\/\/doi.org\/10.1200\/JCO.2007.12.7878","journal-title":"J Clin Oncol"},{"key":"733_CR9","doi-asserted-by":"publisher","unstructured":"Liew LP, Shome A, Wong WW, Hong CR, Hicks KO, Jamieson SMF, et al. (2023) Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers. Molecules 28. https:\/\/doi.org\/10.3390\/molecules28114457.","DOI":"10.3390\/molecules28114457"},{"key":"733_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"FJ Groelly","year":"2023","unstructured":"Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M (2023) Targeting DNA damage response pathways in cancer. Nat Rev Cancer 23:78\u201394. https:\/\/doi.org\/10.1038\/s41568-022-00535-5","journal-title":"Nat Rev Cancer"},{"key":"733_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O'Connor","year":"2015","unstructured":"O\u2019Connor MJ (2015) Targeting the DNA damage response in cancer. Mol Cell 60:547\u2013560. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.040","journal-title":"Mol Cell"},{"key":"733_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1128\/MMBR.63.2.349-404.1999","volume":"63","author":"F Paques","year":"1999","unstructured":"Paques F, Haber JE (1999) Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 63:349\u2013404. https:\/\/doi.org\/10.1128\/MMBR.63.2.349-404.1999","journal-title":"Microbiol Mol Biol Rev"},{"key":"733_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1042\/BJ20080413","volume":"417","author":"BL Mahaney","year":"2009","unstructured":"Mahaney BL, Meek K, Lees-Miller SP (2009) Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 417:639\u2013650. https:\/\/doi.org\/10.1042\/BJ20080413","journal-title":"Biochem J"},{"key":"733_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","volume":"20","author":"R Scully","year":"2019","unstructured":"Scully R, Panday A, Elango R, Willis NA (2019) DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol 20:698\u2013714. https:\/\/doi.org\/10.1038\/s41580-019-0152-0","journal-title":"Nat Rev Mol Cell Biol"},{"key":"733_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.dnarep.2011.12.007","volume":"11","author":"Z Shao","year":"2012","unstructured":"Shao Z, Davis AJ, Fattah KR, So S, Sun J, Lee KJ et al (2012) Persistently bound Ku at DNA ends attenuates DNA end resection and homologous recombination. DNA Repair Amst 11:310\u2013316. https:\/\/doi.org\/10.1016\/j.dnarep.2011.12.007","journal-title":"DNA Repair Amst"},{"key":"733_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm1367","volume":"5","author":"JA Downs","year":"2004","unstructured":"Downs JA, Jackson SP (2004) A means to a DNA end: the many roles of Ku. Nat Rev Mol Cell Biol 5:367\u2013378. https:\/\/doi.org\/10.1038\/nrm1367","journal-title":"Nat Rev Mol Cell Biol"},{"key":"733_CR17","doi-asserted-by":"publisher","first-page":"10375","DOI":"10.1016\/S0021-9258(18)67534-9","volume":"261","author":"T Mimori","year":"1986","unstructured":"Mimori T, Hardin JA (1986) Mechanism of interaction between Ku protein and DNA. J Biol Chem 261:10375\u201310379","journal-title":"J Biol Chem"},{"key":"733_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/0092-8674(95)90482-4","volume":"82","author":"KO Hartley","year":"1995","unstructured":"Hartley KO, Gell D, Smith GC, Zhang H, Divecha N, Connelly MA et al (1995) DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849\u2013856. https:\/\/doi.org\/10.1016\/0092-8674(95)90482-4","journal-title":"Cell"},{"key":"733_CR19","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1128\/MCB.23.16.5836-5848.2003","volume":"23","author":"Q Ding","year":"2003","unstructured":"Ding Q, Reddy YV, Wang W, Woods T, Douglas P, Ramsden DA et al (2003) Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol 23:5836\u20135848. https:\/\/doi.org\/10.1128\/MCB.23.16.5836-5848.2003","journal-title":"Mol Cell Biol"},{"key":"733_CR20","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1128\/MCB.22.14.5194-5202.2002","volume":"22","author":"KN Mahajan","year":"2002","unstructured":"Mahajan KN, Nick McElhinny SA, Mitchell BS, Ramsden DA (2002) Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol 22:5194\u20135202. https:\/\/doi.org\/10.1128\/MCB.22.14.5194-5202.2002","journal-title":"Mol Cell Biol"},{"key":"733_CR21","doi-asserted-by":"publisher","first-page":"33900","DOI":"10.1074\/jbc.M606023200","volume":"281","author":"D Niewolik","year":"2006","unstructured":"Niewolik D, Pannicke U, Lu H, Ma Y, Wang LC, Kulesza P et al (2006) DNA-PKcs dependence of Artemis endonucleolytic activity, differences between hairpins and 5\u2019 or 3\u2019 overhangs. J Biol Chem 281:33900\u201333909. https:\/\/doi.org\/10.1074\/jbc.M606023200","journal-title":"J Biol Chem"},{"key":"733_CR22","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1074\/jbc.M116.770461","volume":"292","author":"D Niewolik","year":"2017","unstructured":"Niewolik D, Peter I, Butscher C, Schwarz K (2017) Autoinhibition of the nuclease ARTEMIS is mediated by a physical interaction between its catalytic and C-terminal domains. J Biol Chem 292:3351\u20133365. https:\/\/doi.org\/10.1074\/jbc.M116.770461","journal-title":"J Biol Chem"},{"key":"733_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/347479a0","volume":"347","author":"GM Fulop","year":"1990","unstructured":"Fulop GM, Phillips RA (1990) The scid mutation in mice causes a general defect in DNA repair. Nature 347:479\u2013482. https:\/\/doi.org\/10.1038\/347479a0","journal-title":"Nature"},{"key":"733_CR24","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1073\/pnas.88.4.1394","volume":"88","author":"KA Biedermann","year":"1991","unstructured":"Biedermann KA, Sun JR, Giaccia AJ, Tosto LM, Brown JM (1991) scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci U S A 88:1394\u20131397. https:\/\/doi.org\/10.1073\/pnas.88.4.1394","journal-title":"Proc Natl Acad Sci U S A"},{"key":"733_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3399","volume":"12","author":"NJ Curtin","year":"2012","unstructured":"Curtin NJ (2012) DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer 12:801\u2013817. https:\/\/doi.org\/10.1038\/nrc3399","journal-title":"Nat Rev Cancer"},{"key":"733_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00005","volume":"4","author":"D Davidson","year":"2013","unstructured":"Davidson D, Amrein L, Panasci L, Aloyz R (2013) Small molecules, inhibitors of DNA-PK, targeting DNA repair, and beyond. Front Pharmacol 4:5. https:\/\/doi.org\/10.3389\/fphar.2013.00005","journal-title":"Front Pharmacol"},{"key":"733_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1080\/09553002.2019.1664787","volume":"95","author":"TW Lee","year":"2019","unstructured":"Lee TW, Wong WW, Dickson BD, Lipert B, Cheng GJ, Hunter FW et al (2019) Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia. Int J Radiat Biol 95:1597\u20131612. https:\/\/doi.org\/10.1080\/09553002.2019.1664787","journal-title":"Int J Radiat Biol"},{"key":"733_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature08648","volume":"463","author":"BL Sibanda","year":"2010","unstructured":"Sibanda BL, Chirgadze DY, Blundell TL (2010) Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats. Nature 463:118\u2013121. https:\/\/doi.org\/10.1038\/nature08648","journal-title":"Nature"},{"key":"733_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1126\/science.aak9654","volume":"355","author":"BL Sibanda","year":"2017","unstructured":"Sibanda BL, Chirgadze DY, Ascher DB, Blundell TL (2017) DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair. Science 355:520\u2013524. https:\/\/doi.org\/10.1126\/science.aak9654","journal-title":"Science"},{"key":"733_CR30","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/cr.2017.110","volume":"27","author":"X Yin","year":"2017","unstructured":"Yin X, Liu M, Tian Y, Wang J, Xu Y (2017) Cryo-EM structure of human DNA-PK holoenzyme. Cell Res 27:1341\u20131350. https:\/\/doi.org\/10.1038\/cr.2017.110","journal-title":"Cell Res"},{"key":"733_CR31","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.2174\/138161209789649484","volume":"15","author":"R Cao","year":"2009","unstructured":"Cao R, Zeng H, Zhang H (2009) 3D-QSAR studies on a series of inhibitors docked into a new homology model of the DNA-PK receptor. Curr Pharm Des 15:3796\u20133825. https:\/\/doi.org\/10.2174\/138161209789649484","journal-title":"Curr Pharm Des"},{"key":"733_CR32","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1016\/j.bmc.2011.05.032","volume":"19","author":"S Ihmaid","year":"2011","unstructured":"Ihmaid S, Al-Rawi J, Bradley C, Angove MJ, Robertson MN, Clark RL (2011) Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines. Bioorg Med Chem 19:3983\u20133994. https:\/\/doi.org\/10.1016\/j.bmc.2011.05.032","journal-title":"Bioorg Med Chem"},{"key":"733_CR33","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1039\/c2ob26035b","volume":"10","author":"KM Clapham","year":"2012","unstructured":"Clapham KM, Rennison T, Jones G, Craven F, Bardos J, Golding BT et al (2012) Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives. Org Biomol Chem 10:6747\u20136757. https:\/\/doi.org\/10.1039\/c2ob26035b","journal-title":"Org Biomol Chem"},{"key":"733_CR34","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","volume":"7","author":"SM Maira","year":"2008","unstructured":"Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C et al (2008) Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 7:1851\u20131863. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0017","journal-title":"Mol Cancer Ther"},{"key":"733_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1593\/neo.111512","volume":"14","author":"B Mukherjee","year":"2012","unstructured":"Mukherjee B, Tomimatsu N, Amancherla K, Camacho CV, Pichamoorthy N, Burma S (2012) The dual PI3K\/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses. Neoplasia 14:34\u201343. https:\/\/doi.org\/10.1593\/neo.111512","journal-title":"Neoplasia"},{"key":"733_CR36","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1021\/jm050444b","volume":"48","author":"IR Hardcastle","year":"2005","unstructured":"Hardcastle IR, Cockcroft X, Curtin NJ, El-Murr MD, Leahy JJ, Stockley M et al (2005) Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem 48:7829\u20137846. https:\/\/doi.org\/10.1021\/jm050444b","journal-title":"J Med Chem"},{"key":"733_CR37","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1158\/0008-5472.CAN-05-4275","volume":"66","author":"Y Zhao","year":"2006","unstructured":"Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ et al (2006) Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res 66:5354\u20135362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4275","journal-title":"Cancer Res"},{"key":"733_CR38","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1021\/jm400915j","volume":"56","author":"C Cano","year":"2013","unstructured":"Cano C, Saravanan K, Bailey C, Bardos J, Curtin NJ, Frigerio M et al (2013) 1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK\/PI3-K inhibitory activity. J Med Chem 56:6386\u20136401. https:\/\/doi.org\/10.1021\/jm400915j","journal-title":"J Med Chem"},{"key":"733_CR39","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/1535-7163.MCT-11-0535","volume":"11","author":"JM Munck","year":"2012","unstructured":"Munck JM, Batey MA, Zhao Y, Jenkins H, Richardson CJ, Cano C et al (2012) Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K. Mol Cancer Ther 11:1789\u20131798. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0535","journal-title":"Mol Cancer Ther"},{"key":"733_CR40","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1158\/0008-5472.CAN-04-4250","volume":"65","author":"ET Shinohara","year":"2005","unstructured":"Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E et al (2005) DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res 65:4987\u20134992. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4250","journal-title":"Cancer Res"},{"key":"733_CR41","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1038\/s41467-019-12836-9","volume":"10","author":"JHL Fok","year":"2019","unstructured":"Fok JHL, Ramos-Montoya A, Vazquez-Chantada M, Wijnhoven PWG, Follia V, James N et al (2019) AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity. Nat Commun 10:5065. https:\/\/doi.org\/10.1038\/s41467-019-12836-9","journal-title":"Nat Commun"},{"key":"733_CR42","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1021\/acs.jmedchem.9b01684","volume":"63","author":"FW Goldberg","year":"2020","unstructured":"Goldberg FW, Finlay MRV, Ting AKT, Beattie D, Lamont GM, Fallan C et al (2020) The discovery of 7-methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor. J Med Chem 63:3461\u20133471. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01684","journal-title":"J Med Chem"},{"key":"733_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1172\/JCI127483","volume":"130","author":"CE Willoughby","year":"2020","unstructured":"Willoughby CE, Jiang Y, Thomas HD, Willmore E, Kyle S, Wittner A et al (2020) Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy. J Clin Invest 130:258\u2013271. https:\/\/doi.org\/10.1172\/JCI127483","journal-title":"J Clin Invest"},{"key":"733_CR44","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/1535-7163.MCT-19-0734","volume":"19","author":"FT Zenke","year":"2020","unstructured":"Zenke FT, Zimmermann A, Sirrenberg C, Dahmen H, Kirkin V, Pehl U et al (2020) Pharmacologic inhibitor of DNA-PK, M3814, potentiates radiotherapy and regresses human tumors in mouse models. Mol Cancer Ther 19:1091\u20131101. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0734","journal-title":"Mol Cancer Ther"},{"key":"733_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41594-020-00517-x","volume":"28","author":"AK Chaplin","year":"2021","unstructured":"Chaplin AK, Hardwick SW, Liang S, Kefala Stavridi A, Hnizda A, Cooper LR et al (2021) Dimers of DNA-PK create a stage for DNA double-strand break repair. Nat Struct Mol Biol 28:13\u201319. https:\/\/doi.org\/10.1038\/s41594-020-00517-x","journal-title":"Nat Struct Mol Biol"},{"key":"733_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41594-022-00881-w","volume":"30","author":"S Liang","year":"2023","unstructured":"Liang S, Blundell TL (2023) Human DNA-dependent protein kinase activation mechanism. Nat Struct Mol Biol 30:140\u2013147. https:\/\/doi.org\/10.1038\/s41594-022-00881-w","journal-title":"Nat Struct Mol Biol"},{"key":"733_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41586-021-04274-9","volume":"601","author":"S Liang","year":"2022","unstructured":"Liang S, Thomas SE, Chaplin AK, Hardwick SW, Chirgadze DY, Blundell TL (2022) Structural insights into inhibitor regulation of the DNA repair protein DNA-PKcs. Nature 601:643\u2013648. https:\/\/doi.org\/10.1038\/s41586-021-04274-9","journal-title":"Nature"},{"key":"733_CR48","doi-asserted-by":"publisher","first-page":"12366","DOI":"10.1021\/acs.jmedchem.4c01120","volume":"67","author":"CR Hong","year":"2024","unstructured":"Hong CR, Liew LP, Wong WW, Dickson BD, Cheng G, Shome A et al (2024) Identification of 6-anilino imidazo[4,5-c]pyridin-2-ones as selective DNA-dependent protein kinase inhibitors and their application as radiosensitizers. J Med Chem 67:12366\u201312385. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01120","journal-title":"J Med Chem"},{"key":"733_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","volume":"25","author":"I Sushko","year":"2011","unstructured":"Sushko I, Novotarskyi S, Korner R, Pandey AK, Rupp M, Teetz W et al (2011) Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information. J Comput Aided Mol Des 25:533\u2013554. https:\/\/doi.org\/10.1007\/s10822-011-9440-2","journal-title":"J Comput Aided Mol Des"},{"key":"733_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/978-1-0716-0150-1_32","volume-title":"Ecotoxicological QSARs","author":"A Mauri","year":"2020","unstructured":"Mauri A (2020) alvaDesc: a tool to calculate and analyze molecular descriptors and fingerprints. In: Roy K (ed) Ecotoxicological QSARs. New York NY, Springer, US, pp 801\u2013820"},{"key":"733_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108991","volume":"180","author":"S Mitra","year":"2024","unstructured":"Mitra S, Halder AK, Koley A, Ghosh N, Panda P, Mandal SC et al (2024) Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-pyrazol amide derivatives: a multi-scale in silico modelling approach. Comput Biol Med 180:108991. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108991","journal-title":"Comput Biol Med"},{"key":"733_CR52","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.drudis.2016.06.013","volume":"21","author":"KAU Danishuddin","year":"2016","unstructured":"Danishuddin KAU (2016) Descriptors and their selection methods in QSAR analysis: paradigm for drug design. Drug Discov Today 21:1291\u20131302. https:\/\/doi.org\/10.1016\/j.drudis.2016.06.013","journal-title":"Drug Discov Today"},{"key":"733_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.70039","volume":"14","author":"S Lesani","year":"2025","unstructured":"Lesani S, Tavalla M, Eslami G, Boozhmehrani MJ (2025) Quantitative structure-activity relationship modeling and molecular docking studies of TgCDPK1 inhibitors in Toxoplasma gondii. Microbiologyopen 14:e70039. https:\/\/doi.org\/10.1002\/mbo3.70039","journal-title":"Microbiologyopen"},{"key":"733_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chemolab.2015.07.007","volume":"147","author":"P Ambure","year":"2015","unstructured":"Ambure P, Aher RB, Gajewicz A, Puzyn T, Roy K (2015) \u201cnanobridges\u201d software: open access tools to perform QSAR and nano-QSAR modeling. Chemometr Intell Lab Syst 147:1\u201313. https:\/\/doi.org\/10.1016\/j.chemolab.2015.07.007","journal-title":"Chemometr Intell Lab Syst"},{"key":"733_CR55","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26:694\u2013701. https:\/\/doi.org\/10.1002\/qsar.200610151","journal-title":"QSAR Comb Sci"},{"key":"733_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","volume":"145","author":"K Roy","year":"2015","unstructured":"Roy K, Kar S, Ambure P (2015) On a simple approach for determining applicability domain of QSAR models. Chemometr Intell Lab Syst 145:22\u201329. https:\/\/doi.org\/10.1016\/j.chemolab.2015.04.013","journal-title":"Chemometr Intell Lab Syst"},{"key":"733_CR57","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1021\/acs.jcim.3c00465","volume":"64","author":"T Tian","year":"2024","unstructured":"Tian T, Li S, Fang M, Zhao D, Zeng J (2024) MolSHAP: interpreting quantitative structure-activity relationships using Shapley values of R-groups. J Chem Inf Model 64:2236\u20132249. https:\/\/doi.org\/10.1021\/acs.jcim.3c00465","journal-title":"J Chem Inf Model"},{"key":"733_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106789","volume":"157","author":"S Mitra","year":"2023","unstructured":"Mitra S, Halder AK, Ghosh N, Mandal SC, Cordeiro M (2023) Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLD. Comput Biol Med 157:106789. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106789","journal-title":"Comput Biol Med"},{"key":"733_CR59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00894-010-0684-x","volume":"17","author":"P Tosco","year":"2011","unstructured":"Tosco P, Balle T (2011) Open3DQSAR: a new open-source software aimed at high-throughput chemometric analysis of molecular interaction fields. J Mol Model 17:201\u2013208. https:\/\/doi.org\/10.1007\/s00894-010-0684-x","journal-title":"J Mol Model"},{"key":"733_CR60","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10822-011-9462-9","volume":"25","author":"P Tosco","year":"2011","unstructured":"Tosco P, Balle T, Shiri F (2011) Open3DALIGN: an open-source software aimed at unsupervised ligand alignment. J Comput Aided Mol Des 25:777\u2013783. https:\/\/doi.org\/10.1007\/s10822-011-9462-9","journal-title":"J Comput Aided Mol Des"},{"key":"733_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020263","author":"I Mondal","year":"2024","unstructured":"Mondal I, Halder AK, Pattanayak N, Mandal SK, Cordeiro M (2024) Shaping the future of obesity treatment: in silico multi-modeling of IP6K1 inhibitors for obesity and metabolic dysfunction. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph17020263","journal-title":"Pharmaceuticals (Basel)"},{"key":"733_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108640","volume":"126","author":"S Mitra","year":"2024","unstructured":"Mitra S, Chatterjee S, Bose S, Panda P, Basak S, Ghosh N et al (2024) Finding structural requirements of structurally diverse alpha-glucosidase and alpha-amylase inhibitors through validated and predictive 2D-QSAR and 3D-QSAR analyses. J Mol Graph Model 126:108640. https:\/\/doi.org\/10.1016\/j.jmgm.2023.108640","journal-title":"J Mol Graph Model"},{"key":"733_CR63","doi-asserted-by":"publisher","first-page":"1004255","DOI":"10.3389\/fphar.2022.1004255","volume":"13","author":"A Ghosh","year":"2022","unstructured":"Ghosh A, Panda P, Halder AK, Cordeiro M (2022) In silico characterization of aryl benzoyl hydrazide derivatives as potential inhibitors of RdRp enzyme of H5N1 influenza virus. Front Pharmacol 13:1004255. https:\/\/doi.org\/10.3389\/fphar.2022.1004255","journal-title":"Front Pharmacol"},{"key":"733_CR64","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"733_CR65","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"733_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-1-62703-059-5_21","volume":"930","author":"P Gramatica","year":"2013","unstructured":"Gramatica P (2013) On the development and validation of QSAR models. Methods Mol Biol 930:499\u2013526. https:\/\/doi.org\/10.1007\/978-1-62703-059-5_21","journal-title":"Methods Mol Biol"},{"key":"733_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejps.2014.05.019","volume":"62","author":"K Roy","year":"2014","unstructured":"Roy K, Kar S (2014) The rm2 metrics and regression through origin approach: reliable and useful validation tools for predictive QSAR models (commentary on \u2019Is regression through origin useful in external validation of QSAR models?\u2019). Eur J Pharm Sci 62:111\u2013114. https:\/\/doi.org\/10.1016\/j.ejps.2014.05.019","journal-title":"Eur J Pharm Sci"},{"key":"733_CR68","volume-title":"Handbook of molecular descriptors","author":"R Todeschini","year":"2008","unstructured":"Todeschini R, Consonni V (2008) Handbook of molecular descriptors. John Wiley & Sons, Place"},{"key":"733_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/qsar.200390007","volume":"22","author":"A Tropsha","year":"2003","unstructured":"Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22:69\u201377. https:\/\/doi.org\/10.1002\/qsar.200390007","journal-title":"QSAR Comb Sci"},{"key":"733_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00733-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:51:25Z","timestamp":1766389885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00733-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00733-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7479073\/v1","asserted-by":"object"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}